Von Hoff
Impact in
- Oncology top 5%
- Cancer Cells and Metastasis
- Metal complexes synthesis and properties
- Cancer Treatment and Pharmacology
- Toxicology top 5%
- Bioactive Compounds and Antitumor Agents
Papers in
- Oncology 20
- Cancer Cells and Metastasis 7
- Colorectal Cancer Treatments and Studies 4
- Pancreatic and Hepatic Oncology Research 3
- Cancer Treatment and Pharmacology 3
-
- Bioactive Compounds and Antitumor Agents 5
- Co-authors
- Marcel Rozencweig (8 shared papers)Martine J Piccart (1 shared paper)Franco M. Muggia (7 shared papers)Young Rc (3 shared papers)Cheryl M. Reichert (1 shared paper)Richard L. Schilsky (1 shared paper)C A Coltman (5 shared papers)S E Salmon (2 shared papers)
- Journals
- PubMed (40 papers)Ghent University Academic Bibliography (Ghent University) (1 paper)
- Partner nations
- United StatesBelgium
In The Last Decade
Von Hoff
41 papers receiving 1k citations
Peers
Comparison fields: 5 of 68
- Oncology 391
- Toxicology 60
- Otorhinolaryngology 42
- Cardiology and Cardiovascular Medicine 176
- Pathology and Forensic Medicine 115
Countries citing papers authored by Von Hoff
This map shows the geographic impact of Von Hoff's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Von Hoff with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Von Hoff more than expected).
Fields of papers citing papers by Von Hoff
This network shows the impact of papers produced by Von Hoff. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Von Hoff. The network helps show where Von Hoff may publish in the future.
Co-authors
The 25 scholars most cited alongside Von Hoff, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 41 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Toxic effects of cis-dichlorodiammineplatinum(II) in man. | 1980 | 307 |
| 2 | The cardiotoxicity of anticancer agents. | 1982 | 176 |
| 3 | Activity of mitoxantrone in a human tumor cloning system. | 1981 | 81 |
| 4 | In vitro assessment of the effects of granulocyte-macrophage colony-stimulating factor on primary human tumors and derived lines. | 1990 | 53 |
| 5 | In vitro evaluation of anticancer drugs with the human tumor stem cell assay. | 1981 | 47 |
| 6 | Phase I study of ICRF-187 using a daily for 3 days schedule. | 1981 | 41 |
| 7 | Phase I study of methanesulfonamide, N-[4-(9-acridinylamino)-3-methoxyphenyl]-(m-AMSA) using a single-dose schedule. | 1978 | 40 |
| 8 | Comparison of the human tumor cloning and subrenal capsule assays. | 1984 | 36 |
| 9 | Use of an image analysis system to count colonies in stem cell assays of human tumors. | 1980 | 35 |
| 10 | Initial experience with the human tumor stem cell assay system: potential and problems. | 1980 | 32 |
| 11 | Mitoxantrone in refractory nonHodgkin's lymphoma. A Southwest Oncology Group study. | 1984 | 32 |
| 12 | Acute ventricular fibrillation and death during infusion of 4'-(9-acridinylamino)methanesulfon-m-anisidide (AMSA). | 1980 | 27 |
| 13 | Utilization of a human tumor cloning system to monitor for marrow involvement with small cell carcinoma of the lung. | 1981 | 26 |
| 14 | Mitoxantrone: modest activity in a phase II trial in advanced prostate cancer. | 1983 | 26 |
| 15 | Investigational chemotherapeutic agents in head and neck cancer. | 1977 | 24 |
| 16 | Use of a human tumor cloning system to evaluate analogs of methotrexate and mitoxantrone. | 1984 | 23 |
| 17 | Risk factors for development of daunorubicin cardiotoxicity. | 1981 | 22 |
| 18 | Phase II study of fludarabine phosphate in previously untreated patients with hepatoma: a Southwest Oncology Group Study. | 1987 | 14 |
| 19 | Alternative dosing schedules for irinotecan. | 1998 | 13 |
| 20 | Plasma and cerebrospinal fluid pharmacokinetics of acivicin in Ommaya reservoir-bearing rhesus monkeys. | 1982 | 12 |
About Von Hoff
Von Hoff is a scholar working on Oncology, Toxicology, Cancer Research, Molecular Biology and Cardiology and Cardiovascular Medicine, having authored 41 papers that have together received 1.2k indexed citations. Recurring topics across this work include Cancer therapeutics and mechanisms (9 papers), Cancer Cells and Metastasis (7 papers), Bioactive Compounds and Antitumor Agents (5 papers), Colorectal Cancer Treatments and Studies (4 papers), Pancreatic and Hepatic Oncology Research (3 papers), Chemotherapy-induced cardiotoxicity and mitigation (3 papers), Cancer Treatment and Pharmacology (3 papers) and Breast Cancer Treatment Studies (3 papers). The work is most often cited by research in Oncology (391 citations), Toxicology (60 citations), Otorhinolaryngology (42 citations), Cardiology and Cardiovascular Medicine (176 citations) and Pathology and Forensic Medicine (115 citations). Von Hoff has collaborated with scholars based in United States and Belgium. Frequent co-authors include Marcel Rozencweig, Martine J Piccart, Franco M. Muggia, Young Rc, Cheryl M. Reichert, Richard L. Schilsky, C A Coltman, S E Salmon, Barbara J. Forseth and Daniel L. Glaubiger. Their work appears in journals such as PubMed and Ghent University Academic Bibliography (Ghent University).
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.